diabetes glp-1 agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Research GLP-1 receptor agonists for individualized

The authors highlighted their stepwise approach to insulin reduction, which involved prompt weekly insulin dose decreases of 1020% when preprandial or fasting glucose levels were consistently between 80 and 130 mg/dL

They offer cost-effective treatment options because they can self-amplify and autonomously produce therapeutic agents

However, not all of them have been approved as weight loss drugs

The nutrient depletion risks with GLP-1s mirror findings from bariatric surgery literaturevitamin D, B12, and iron often decline with reduced intake

Table of Contents What Are GLP-1 Receptor Agonists and How Do They Work